Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 225

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?

Open access
Hellings, P. W., Fokkens, W. J., Akdis, C., Bachert, C., Cingi, C., Dietz de Loos, D., Gevaert, P., Hox, V., Kalogjera, L., Lund, V., Mullol, J., Papadopoulos, N. G., Passalacqua, G., Rondón, C., Scadding, G., Timmermans, M., Toskala, E., Zhang, N., Bousquet, J.·2013·Allergy

Abstract

State‐of‐the‐art documents like ARIA and EPOS provide clinicians with evidence‐based treatment algorithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS), respectively. The currently available medications can alleviate symptoms associated with AR and RS. In real life, a significant percentage of patients with AR and CRS continue to experience bothersome symptoms despite adequate treatment. This group with so‐called severe chronic upper airway disease (SCUAD) represents a therapeutic challenge. The concept of control of disease has only recently been introduced in the field of AR and CRS. In case of poor control of symptoms despite guideline‐directed pharmacotherapy, one needs to consider the presence of SCUAD but also treatment‐related, diagnosis‐related and/or patient‐related factors. Treatment‐related issues of uncontrolled upper airway disease are linked with the correct choice of treatment and route of administration, symptom‐oriented treatment and the evaluation of the need for immunotherapy in allergic patients. The diagnosis of AR and CRS should be reconsidered in case of uncontrolled disease, excluding concomitant anatomic nasal deformities, global airway dysfunction and systemic diseases. Patient‐related issues responsible for the lack of control in chronic upper airway inflammation are often but not always linked with adherence to the prescribed medication and education. This review is an initiative taken by the ENT section of the EAACI in conjunction with ARIA and EPOS experts who felt the need to provide a comprehensive overview of the current state of the art of control in upper airway inflammation and stressing the unmet needs in this domain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/all.12040

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 225

Metadata

Authors
Hellings, P. W., Fokkens, W. J., Akdis, C., Bachert, C., Cingi, C., Dietz de Loos, D., Gevaert, P., Hox, V., Kalogjera, L., Lund, V., Mullol, J., Papadopoulos, N. G., Passalacqua, G., Rondón, C., Scadding, G., Timmermans, M., Toskala, E., Zhang, N., & Bousquet, J.
Venue
Allergy
Publisher
Wiley
Published
2012-10
Volume
68
Issue
1
Pages
1-7
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W2056448247
Cited by
225
References
2
FWCI
11.25
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? https://app.cochat.ai/papers/10.1111/all.12040
The paper
Hellings, P. W., Fokkens, W. J., Akdis, C., Bachert, C., Cingi, C., Dietz de Loos, D., Gevaert, P., Hox, V., Kalogjera, L., Lund, V., Mullol, J., Papadopoulos, N. G., Passalacqua, G., Rondón, C., Scadding, G., Timmermans, M., Toskala, E., Zhang, N., & Bousquet, J. (2013). Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy. https://doi.org/10.1111/all.12040

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.